Clorox CO CLX
We take great care to ensure that the data presented and summarized in this overview for CLOROX CO is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CLX
View all-
Vanguard Group Inc Valley Forge, PA15.3MShares$2.42 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.9MShares$1.72 Billion0.03% of portfolio
-
State Street Corp Boston, MA7.94MShares$1.25 Billion0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA2.99MShares$472 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.83MShares$446 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$387 Million0.03% of portfolio
-
Stifel Financial Corp St. Louis, MO2.3MShares$362 Million0.36% of portfolio
-
Royal Bank Of Canada Toronto, A61.66MShares$262 Million0.05% of portfolio
-
Nuance Investments, LLC Kansas City, MO1.6MShares$252 Million7.53% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.56MShares$246 Million1.35% of portfolio
Latest Institutional Activity in CLX
Top Purchases
Top Sells
About CLX
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.
Insider Transactions at CLX
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 04
2024
|
Laurene E Peck VP - CAO & Corp Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-4.72%
|
$74,543
$161.57 P/Share
|
Oct 04
2024
|
Laurene E Peck VP - CAO & Corp Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,105
+18.18%
|
$177,905
$161.57 P/Share
|
Oct 04
2024
|
Linda J Rendle Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,976
-1.1%
|
$479,136
$161.57 P/Share
|
Oct 04
2024
|
Linda J Rendle Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,639
+19.32%
|
$5,254,879
$161.57 P/Share
|
Oct 04
2024
|
Eric H Reynolds EVP - Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
837
-0.75%
|
$134,757
$161.57 P/Share
|
Oct 04
2024
|
Eric H Reynolds EVP - Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,205
+17.91%
|
$1,965,005
$161.57 P/Share
|
Oct 04
2024
|
Kirsten Marriner EVP - Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,958
-3.92%
|
$476,238
$161.57 P/Share
|
Oct 04
2024
|
Kirsten Marriner EVP - Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,898
+15.32%
|
$1,110,578
$161.57 P/Share
|
Oct 04
2024
|
Stacey Grier EVP - Executive Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
1,079
-1.69%
|
$173,719
$161.57 P/Share
|
Oct 04
2024
|
Stacey Grier EVP - Executive Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
6,260
+13.18%
|
$1,007,860
$161.57 P/Share
|
Oct 04
2024
|
Angela C Hilt EVP - Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,192
-6.47%
|
$513,912
$161.57 P/Share
|
Oct 04
2024
|
Angela C Hilt EVP - Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,368
+20.26%
|
$1,025,248
$161.57 P/Share
|
Oct 04
2024
|
Chris T Hyder EVP-Group Pres -Hlth & Hyg |
SELL
Payment of exercise price or tax liability
|
Direct |
972
-1.37%
|
$156,492
$161.57 P/Share
|
Oct 04
2024
|
Chris T Hyder EVP-Group Pres -Hlth & Hyg |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+10.27%
|
$837,200
$161.57 P/Share
|
Oct 04
2024
|
Kevin B Jacobsen EVP - Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
750
-0.73%
|
$120,750
$161.57 P/Share
|
Oct 04
2024
|
Kevin B Jacobsen EVP - Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,613
+17.11%
|
$1,708,693
$161.57 P/Share
|
Sep 30
2024
|
Christopher J Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
199
+23.47%
|
$32,238
$162.91 P/Share
|
Sep 30
2024
|
Amy Banse Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+23.5%
|
$26,082
$162.91 P/Share
|
Sep 30
2024
|
Paul Gray Parker Director |
BUY
Grant, award, or other acquisition
|
Direct |
80
+7.56%
|
$12,960
$162.91 P/Share
|
Sep 17
2024
|
Kevin B Jacobsen EVP - Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,800
+14.31%
|
$1,115,200
$164.69 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 224K shares |
---|
Payment of exercise price or tax liability | 15.2K shares |
---|---|
Open market or private sale | 1.73K shares |